Open menu

RSS Subscribe to our Nanotechnology Business News feed

Multiple Studies Showcase Abraxis BioScience's Proprietary Tumor Targeting Technology

Abraxis BioScience Inc. today announced that multiple studies showcasing its proprietary tumor targeting technology, known as the nab (nanoparticle albumin-bound) technology platform, and secreted protein acidic and rich in cysteine (SPARC) biomarker will be presented at the American Association for Cancer Research (AACR) Annual Meeting in Denver, April 18-22, 2009.

Posted: Apr 21st, 2009

Read more

Chinese HB-LED Manufacturer Qualifies Veeco's MOCVD System

Veeco Instruments Inc. announced today that Shandong Raysun Huaguang Optoelectronics Co., Ltd. of China has qualified Veeco's gallium nitride and arsenic phosphide metal organic chemical vapor deposition systems for high volume production of red and blue high-brightness light emitting diodes.

Posted: Apr 20th, 2009

Read more